Is It Time To Reassess Array Technologies (ARRY) After The Recent Share Price Slide

  • Wondering if Array Technologies at around US$6.84 is a bargain or a value trap? This article walks through what the current price might be implying.
  • The stock has fallen 21.9% over the past week, 21.7% over the past month, 29.4% year to date, and 12.0% over the past year. This may signal that market expectations and perceived risk around the stock have shifted.
  • Recent coverage has focused on Array Technologies as a solar equipment provider in a sector where investor sentiment can swing quickly with changes in policy support, interest rates, or funding conditions. This context helps explain why the stock price can move sharply when new information affects how investors view future project pipelines or financing conditions.
  • On Simply Wall St’s valuation checks, Array Technologies records a value score of 4 out of 6. Next, the article will walk through what different valuation approaches say about that score, before finishing with a broader way to think about valuation beyond the headline numbers.

Find out why Array Technologies's -12.0% return over the last year is lagging behind its peers.

Advertisement

Approach 1: Array Technologies Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a stock could be worth by projecting the company’s future cash flows and then discounting those back to today’s value using a required return. It is essentially asking what those future dollars are worth in today’s terms.

For Array Technologies, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month Free Cash Flow is about $68.8 million, and analyst-based plus extrapolated estimates indicate Free Cash Flow of $115 million in 2030, with interim projections between these points supplied by analysts for several years and then extended by Simply Wall St beyond that horizon.

Aggregating and discounting these projected cash flows results in an estimated intrinsic value of about $7.67 per share. Compared to a current share price of roughly $6.84, the DCF output implies the stock is about 10.9% below that estimate, which suggests Array Technologies screens as modestly undervalued on this model alone.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Array Technologies is undervalued by 10.9%. Track this in your watchlist or portfolio, or discover 48 more high quality undervalued stocks.

ARRY Discounted Cash Flow as at Jun 2026
ARRY Discounted Cash Flow as at Jun 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Array Technologies.

Approach 2: Array Technologies Price vs Sales

For companies where earnings can be volatile or where profits are still developing, the P/S ratio is often a useful way to compare what investors are paying for each dollar of revenue. It is simpler than earnings based metrics and avoids issues that come from short term swings in profitability.

Expectations for growth and the level of risk usually influence what counts as a normal P/S ratio, with higher expected growth or lower perceived risk often lining up with a higher multiple, and the reverse also being true. Array Technologies currently trades on a P/S of about 0.87x, compared with an Electrical industry average of 2.48x and a peer group average of 3.27x.

Simply Wall St’s Fair Ratio for Array Technologies is 1.69x P/S. This is a proprietary estimate of what the multiple might be given factors like earnings growth, industry, profit margins, market cap and risks. Because it adjusts for these company specific characteristics, it can be more tailored than a simple comparison with peers or the broad industry.

Comparing the Fair Ratio of 1.69x with the current P/S of 0.87x suggests the stock screens as undervalued on this metric.

Result: UNDERVALUED

NasdaqGM:ARRY P/S Ratio as at Jun 2026
NasdaqGM:ARRY P/S Ratio as at Jun 2026

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Upgrade Your Decision Making: Choose your Array Technologies Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives on Simply Wall St give you a simple way to attach your story about Array Technologies to the numbers by linking a view on its future revenue, earnings and margins to a financial forecast, a fair value, and then a clear comparison of that fair value with the current share price. All of this is presented within an accessible Community page tool that updates when fresh news or earnings arrive and can reflect very different perspectives, such as a bullish view that assumes a fair value around US$14.06 based on faster growth and higher margins, or a more cautious view closer to US$7 based on slower growth and thinner margins.

Do you think there's more to the story for Array Technologies? Head over to our Community to see what others are saying!

NasdaqGM:ARRY 1-Year Stock Price Chart
NasdaqGM:ARRY 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGM:ARRY

Array Technologies

Engages in the manufacture and sale of solar tracking technology products in the United States, Spain, Brazil, Australia, and internationally.

Undervalued with excellent balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0